Real Options Pricing Model in Biotech ValuationREAL OPTIONS IN BIOTECHNOLOGICAL FIRMS VALUATION. AN EMPIRICAL ANALYSIS OF EUROPEAN FIRMS. Attachments Ziopharm Oncology Thesis.pdf